Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs EXR✓SelectedUSD · EXRGSK vs EXR performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs EXR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
EXR return
+221.8%
Excess return
-124.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioEXRExcessAlpha
1D-0.1%-0.7%+0.5%0.0%
7D-5.3%-2.3%-3.1%-4.8%
30D-3.7%+10.8%-14.4%-6.0%
3M-7.3%+6.4%-13.7%-8.7%
6M-4.2%+11.4%-15.6%-6.7%
YTD+0.9%+23.1%-22.2%-4.1%
1Y+7.3%+25.9%-18.7%+1.5%
3Y+52.7%+36.4%+16.3%+41.0%
5Y+40.1%-6.0%+46.1%+37.9%
All+97.1%+221.8%-124.7%+50.2%

Cumulative growth

Daily Returns

Daily percentage return beside EXR.

Daily Out/Under-Performance

Portfolio return minus EXR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EXR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded EXR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling